Search Results (672)

The manufacturing of detergent products such as laundry detergents or household cleaners is of increasing interest to the chemical industry. Surfactants and fatty acids are the most important ingredients in detergent formulations, as they are responsible for the cleaning power and the antimicrobial efficiency of the cleaning product. Computational tools can play a key role in the design and performance optimization of detergent products as they allow for quick and efficient screening of candidate surfactants in detergent formulations. In the present study, an automated fragmentation and parametrization protocol is utilized to investigate the adsorption of candidate fatty acid surfactants towards bacterial inner membranes. The effect of the surfactant size, concentration, and tendency for micelle formation on the degree of their adsorption on the inner membrane is examined. Analysis demonstrates that surfactant–inner membrane interaction weakens with surfactant size and aggregation tendency, as confirmed by pertinent experimental and simulation studies. The outcome of this study demonstrates that the adopted multiscale protocol allows for an accurate and cost-effective description of the systems examined at timescales much shorter than those required in laboratory experiments and atomistic simulations. Full article

Biomimetic lipid platforms provide versatile tools for mimicking various types of biological membranes and enable investigation of how industrially important amphiphiles (e.g., permeation enhancers and surfactants) interact with different membrane compositions. For example, antimicrobial lipids such as medium-chain fatty acids (FAs) and monoglycerides (MGs) are promising antibiotic alternatives that disrupt bacterial membranes and their distinct mechanisms of action are a topic of ongoing interest. The potency and targeting spectrum of individual antimicrobial lipids vary and mixing different lipids can improve functional activities. Biophysical studies indicate that optimally tuned mixtures exhibit greater disruption of synthetic lipid bilayers; however, their activity against more complex bacterial membrane compositions is largely unexplored. Herein, we applied electrochemical impedance spectroscopy (EIS) to investigate how two MG/FA pairs—composed of 10-carbon long monocaprin (MC) with capric acid (CA) and 12-carbon long glycerol monolaurate (GML) with lauric acid (LA)—disrupt tethered lipid bilayers composed of Escherichia coli bacterial lipids. While MC and CA individually inhibit E. coli, MC/CA mixtures at intermediate ratios displayed synergistic membrane-disruptive activity. Mechanistic studies showed that this synergistic activity depends on the MC/CA molar ratio rather than total lipid concentration. In contrast, GML/LA mixtures had weak membrane interactions across all tested ratios and lacked synergy, which is consistent with their low activity against E. coli. Together, the EIS results reveal that an effective disruption synergy against target membranes can arise from combining individually active antimicrobial lipids with distinct membrane-interaction profiles, laying the foundation to develop potent antimicrobial lipid formulations for tackling antibiotic-resistant bacteria. Full article

Matrix metalloproteinase-9 (MMP-9) is a zinc-dependent endopeptidase that plays a central role in extracellular matrix (ECM) remodeling, angiogenesis, immune cell trafficking, and cytokine activation. Dysregulated MMP-9 activity has been implicated in the pathogenesis of diverse conditions, including atherosclerosis, aneurysm formation, chronic obstructive pulmonary disease (COPD), asthma, neurodegeneration, and malignancy. Although broad-spectrum synthetic MMP inhibitors were initially developed as therapeutic agents, clinical trials failed due to lack of selectivity, poor tolerability, and impairment with physiological tissue repair. This outcome has shifted attention toward indirect pharmacological modulation of MMP-9 using drugs that are already approved for other indications. In this paper, we review the evidence supporting MMP-9 modulation by established therapeutics and adjunctive strategies. Cardiometabolic agents such as statins, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), metformin, and pioglitazone reduce MMP-9 expression and enzymatic activity, contributing to vascular protection, improved insulin sensitivity, and attenuation of aneurysm progression. Anti-inflammatory and respiratory drugs, including glucocorticoids, phosphodiesterase-4 (PDE4) inhibitors, macrolide antibiotics, montelukast, and nonsteroidal anti-inflammatory drugs (NSAIDs), suppress MMP-9-driven airway inflammation and pathological tissue remodeling in asthma, COPD, and acute lung injury. Tetracycline derivatives, particularly sub-antimicrobial dose doxycycline, directly inhibit MMP-9 activity and are clinically validated in the treatment of periodontal disease and vascular remodeling. Hormone-related therapies such as rapamycin, estradiol, and tamoxifen exert tissue- and disease-specific effects on MMP-9 within endocrine and oncologic pathways. In parallel, nutritional interventions—most notably omega-3 polyunsaturated fatty acids and antioxidant vitamins—provide adjunctive strategies for mitigating MMP-9 activity in chronic inflammatory states. Taken together, these findings position MMP-9 as a modifiable and clinically relevant therapeutic target. The systematic integration of approved pharmacologic agents with lifestyle and nutritional interventions into disease-specific treatment paradigms may facilitate safer, context-specific modulation of MMP-9 activity and unveil novel opportunities for therapeutic repurposing. Full article

Mastitis represents one of the most economically devastating diseases in dairy production, causing billions of dollars in annual losses through reduced milk quality and quantity. Recent advances in microbiome research have unveiled a critical gut–mammary axis that fundamentally influences mastitis susceptibility and pathogenesis in dairy cattle. Through comprehensive analysis of microbial communities across multiple anatomical sites, we demonstrate that mastitis development involves systematic disruption of both mammary and gastrointestinal microbiomes, characterized by reduced beneficial bacterial populations and increased pathogenic species. Healthy animals maintain balanced microbial ecosystems dominated by protective taxa including Firmicutes, Bacteroidetes, and beneficial Lactobacillus species, while mastitis-affected animals exhibit dysbiotic shifts toward Proteobacteria dominance, elevated Streptococcus and Staphylococcus populations, and compromised microbial diversity. Mechanistic investigations reveal that gut microbiota disruption compromises systemic immune competence, alters metabolite production including short-chain fatty acids and bile acids, and influences inflammatory mediators that circulate to mammary tissue. Therapeutic interventions targeting this axis, including probiotics, prebiotics, and plant-derived compounds, demonstrate significant efficacy in restoring microbiome homeostasis and reducing mastitis severity. These findings establish the gut–mammary axis as a fundamental regulatory mechanism in mastitis pathogenesis, opening new avenues for microbiome-based prevention and treatment strategies that could significantly enhance dairy health management while addressing antimicrobial resistance concerns. Full article

Aquaculture is expanding rapidly worldwide, but its sustainability is threatened by intensive production practices, environmental stressors and recurrent disease outbreaks. Natural feed additives are increasingly studied as alternatives to antibiotics and synthetic compounds. Among them, bee-derived products—pollen, bee bread, propolis, royal jelly, honey and fermented derivatives—represent a promising resource due to their richness in proteins, amino acids, fatty acids, vitamins, flavonoids and phenolic compounds with demonstrated antioxidant, antimicrobial and immunostimulant properties. Evidence from studies on species such as Nile tilapia, rainbow trout, European sea bass, meagre and African catfish indicates that dietary supplementation with bee products can improve growth performance, immune and antioxidant responses, stress tolerance and resistance to bacterial infections while, in some cases, enhancing the nutritional value and shelf-life of fish products. Prominent examples include ~45% higher growth in African catfish with 10–30 g kg⁻¹ bee pollen, up to 93% protection in Nile tilapia fed 25 g kg⁻¹ pollen against Aeromonas hydrophila, and increased trout fillet carotenoids with pollen-derived pigments (with overall growth unchanged and pigmentation lower than synthetic astaxanthin). Conversely, meagre fed 20–40 g kg⁻¹ raw pollen showed reduced growth and digestibility with elevated intestinal stress markers, underscoring species- and dose-specific responses. Nevertheless, the available data remain fragmented and heterogeneous, reflecting differences in product type, origin, dosage and experimental design. This review critically analyses the current knowledge on bee products in aquaculture nutrition, identifies the main gaps and limitations, and outlines future research directions. By linking fish physiology, nutritional strategies and product quality, bee-derived products emerge as innovative tools for promoting fish health and resilience in sustainable aquaculture. Full article

In response to the increasing interest in medicinal plants, researchers have called for the investigation of underexplored, widely distributed species, such as those within the Camellia genus. Camellia japonica L., though not native to Galicia (NW Spain), is widely cultivated there, primarily for ornamental purposes. Recent phytochemical analyses of C. japonica leaves have identified a variety of bioactive compounds, with phenolic compounds being the most abundant, along with carotenoids, terpenoids and fatty acids. These molecules exhibit a range of biological activities, including antioxidant, antimicrobial, anti-inflammatory, and anticancer effects. Nonetheless, certain constituents, such as saponins, triterpenes, and tannins, may exhibit anti-nutritional or mild toxic effects under specific conditions. This review specifically examines the bioactive compounds found in C. japonica leaves and their associated health benefits. Furthermore, it underscores the need for innovative approaches to develop sustainable industrial processes for utilizing C. japonica leaves, with potential applications in the food, pharmaceutical, and cosmetic industries. Full article

Worldwide, the genus Echium L. (Boraginaceae) is represented by over 60 species of herbaceous plants and shrubs. The species are widely distributed all around the Mediterranean basin, Europe, and the Macaronesian Islands and are known for their analgesic, diuretic, antioxidant, antimicrobial, and antitumor properties. In traditional medicine, they are widely used as a wound-healing and anti-inflammatory agent, for respiratory problems and problems related to mental health, and for general abrasions and fissures of the hands. Four species are naturally distributed in Bulgaria—E. russicum J.F. Gmel., E. vulgare L., E. italicum L., E. plantagineum L., the first three being medicinal. The review aims to summarize the literature describing the content of biologically active substances and the therapeutic effects of Echium spp., with an emphasis on medicinal species distributed in Bulgaria. The content of biologically active substances was monitored, in particular, terpenes, phenolic compounds, flavonoids, naphthoquinones, omega-3 and omega-6 fatty acids, and pyrrolizidine alkaloids. The relationship between bioactive compounds, biological activities, and medicinal uses was researched. After the analysis made in the present review, it can be summarized: Despite extensive research, knowledge of their pharmacological potential is still incomplete. An attempt has therefore been made to outline directions for future research. Full article

The growing emergence of multidrug-resistant bacterial pathogens drives the need for new antibacterial agents. Punicalagin exhibits efficacy against methicillin-resistant Staphylococcus aureus (MRSA), but its specific antibacterial mechanisms remain unclear. This study unveiled the specific antibacterial mechanism of punicalagin against MRSA via phenotypic and transcriptomic analyses. Punicalagin was found to induce severe cell wall damage and membrane disruption. Competitive binding assays identified lipoteichoic acid (LTA) as a potential target, and transcriptomic analysis further revealed that punicalagin downregulated key genes involved in cell wall synthesis (murA, murE) and LTA biosynthesis (dltA-D), consistent with the disruption of the cell wall. Additionally, punicalagin disrupted membrane homeostasis by inhibiting fatty acid synthesis (fabD, fabZ) and amino acid metabolism (dapA, dapB), leading to increased membrane permeability, which aligned with the phenotypic manifestations of membrane damage. Collectively, this work links phenotypic changes to specific gene expression patterns, unveiling that punicalagin inactivates MRSA via the multi-pathway regulation of the cell wall (LTA) and membrane function—providing insights for combating antibiotic-resistant pathogens in food safety and clinical settings. Full article

The growing prevalence of antimicrobial resistance has significantly compromised the efficacy of conventional antibiotic-based interventions in controlling Salmonella infections across human and veterinary settings. This growing challenge necessitates a strategic rethinking of pathogen control, prompting the integration of next-generation therapeutics capable of disrupting Salmonella pathogenesis through novel, antibiotic-sparing mechanisms. In this context, a diverse array of emerging alternatives, including bacteriophages, antimicrobial peptides, probiotics, prebiotics, short-chain fatty acids, nanoparticles, and host-directed immunomodulators, have gained prominence as a promising frontier in non-antibiotic therapeutics. These modalities offer targeted approaches to inhibit Salmonella colonization, virulence expression, and persistence, while minimizing collateral damage to the microbiota and avoiding the propagation of resistance genes. As Salmonella continues to pose a global threat to animal and public health, the development of scalable, resistance-conscious interventions remains a critical priority. Ongoing research efforts are increasingly focused on optimizing delivery systems, dosage strategies, and synergistic combinations to enhance the clinical and field applicability of these alternatives. By harnessing these innovative modalities, the future of Salmonella control may shift toward precision therapeutics that align with One Health principles and sustainable food safety goals. Full article

Bacterial vaginosis (BV) is a highly prevalent vaginal infection characterized by a dysbiotic shift in the vaginal microbiota, with Gardnerella vaginalis acting as a principal pathogen. Despite its association with adverse reproductive outcomes, BV remains underexplored from both mechanistic and therapeutic standpoints. Standard antibiotic regimens frequently fail due to high recurrence rates driven by multidrug-resistant (MDR) G. vaginalis strains and biofilm formation. In response, natural compounds and nutraceuticals, owing to their intrinsic antibacterial, antibiofilm, and immunomodulatory properties, have emerged as promising candidates for alternative BV therapies. In this paper, we first compile and critically evaluate preclinical and clinical evidence on the efficacy of plant extracts, essential oils (EOs), probiotics, vitamins, proteins, fatty acids, and enzymes against G. vaginalis, emphasizing their mechanistic insights in restoring vaginal microbial balance. Next, we focus on the integration of these bioactive agents into engineered nanosystems, such as lipid-based nanoparticles (LNPs), polymeric carriers, and inorganic nanostructures, to overcome limitations related to solubility, stability, and targeted delivery. Nonetheless, comparative studies, combination therapies, and recent patent developments are discussed to highlight how naturally derived molecules can enhance antimicrobial potency and reduce cytotoxicity. In conclusion, these platforms demonstrate superior in vitro and in vivo efficacy, offering a paradigm shift in the management of BV. Key challenges include scalable manufacturing, regulatory approval, and comprehensive safety assessment. Future research should prioritize standardized nanoparticle (NP) synthesis, detailed pharmacokinetic and toxicity profiling, and well-designed clinical trials to validate nature-inspired, nanoengineered therapies against G. vaginalis-induced BV. Full article

Palmitoylethanolamide (PEA) is a naturally occurring fatty acid amide and an endocannabinoid-related lipid that has been extensively studied for its analgesic, immunomodulatory, antimicrobial, and anti-inflammatory properties. It has demonstrated efficacy in various applications and is currently utilized as a nutraceutical for its antinociceptive, neuroprotective, and immunomodulatory effects, particularly in supporting brain and joint health and in mitigating inflammatory processes. Background/Objectives: Despite its significant therapeutic potential, the clinical effectiveness of PEA is limited by its poor water solubility and, consequently, low oral bioavailability. Additionally, degradation in the acidic gastrointestinal environment further compromises its absorption. To address these challenges, several technological strategies have been explored to improve its pharmacokinetic profile, including conventional micronization and ultra-micronization techniques. The objective of this study was to characterize a novel liposomal formulation based on PEA and evaluate its intestinal permeation and absorption. Methods: Comparative permeation studies of PEA were conducted using ex vivo models to evaluate its absorption characteristics across gastrointestinal mucosae. The experiments were performed in a Franz diffusion cell system using a porcine colon mucosa in two physiologically relevant media: Simulated Gastric Fluid (SGF) and Fasted State Simulated Intestinal Fluid (FaSSIF). Results: Liposomal PEA showed a more efficient and continuous release over time, reaching higher concentrations of PEA permeated through the membrane. Conclusions: Our findings demonstrate a significant improvement in PEA’s permeability and absorption in an ex vivo simulated gastrointestinal environment. Liposomal PEA appears to be more affine to biological membranes. These results suggest that liposomal PEA may represent a promising therapeutic strategy for managing chronic pain and inflammatory conditions such as chronic pelvic pain. Full article

To address the limitation of traditional broad-spectrum antimicrobial agents in compromising skin microbiota homeostasis, this study developed Lactobacillus plantarum fermented milk (FM) as an innovative strategy for selectively regulating microbial communities to restore skin microbiota balance. FM was produced through protease hydrolysis in combination with L. plantarum fermentation. Selective antibacterial properties were evaluated via monoculture experiments (Escherichia coli, Staphylococcus aureus, and Staphylococcus epidermidis) and pathogen–commensal co-culture systems. It was found that FM can selectively inhibit pathogens (E. coli and S. aureus) and promote the growth of commensal bacteria (S. epidermidis) in monoculture, and can reduce the growth and competitiveness of E. coli and S. aureus while relatively increasing the colony count of S. epidermidis in the co-culture system. Metabolomic profiling was further performed to identify metabolic alterations induced by FM. It was found that FM can activate the pyruvate metabolic node, significantly enhancing the metabolic fluxes of lactic acid, citric acid, and short-chain fatty acids, which triggered the acid stress response of pathogenic bacteria while consuming a considerable amount of energy, attenuating their reproductive capacity without impacting the growth of commensal bacteria. Overall, FM showed selective antimicrobial activity against pathogens (E. coli, and S. aureus) and preservation of commensal S. epidermidis, offering a foundational reference for the development of postbiotics aimed at maintaining cutaneous microbial homeostasis. Full article

Coconut oil is highly regarded for its nutritional and functional attributes, making it an attractive candidate for diverse food and health applications. This study evaluates the fatty acid profile, antioxidant and antimicrobial activities, oxidative stability, and sensory properties of selected coconut oils (Coco24, Health, Kospa, Smetol, and Vita) from the Slovak republic market. Acid values (0.09 ± 0.060–0.42 ± 0.060 mg KOH/g) and peroxide values (0.51 ± 0.058–1.20 ± 0.010 mmol O₂/kg) were within recommended safety limits. Oxidative stability varied significantly (p ˂ 0.05), with Smetol showing the highest induction time (124.5 ± 0.98 h) and Coco24 the lowest (25.8 ± 0.22 h). DPPH antioxidant activity was highest in health (469.2 ± 2.01 mg TEAC/kg) and Coco24 (369.3 ± 1.99 mg TEAC/kg) (TEAC—Trolox equivalent antioxidant capacity). Coco24, Health, and Kospa exhibited the most potent antimicrobial activity against Staphylococcus aureus (2.01 ± 0.001 mm, 1.37 ± 0.021 mm, 1.15 ± 0.010 mm, respectively), Candida glabrata (1.17 ± 0.015 mm, 1.17 ± 0.015 mm, 0.45 ± 0.025 mm, respectively), Candida tropicalis (2.12 ± 0.017 mm, 2.13 ± 0.017 mm, 1.52 ± 0.006 mm, respectively), and Bacillus subtilis (1.29 ± 0.055 mm, 1.35 ± 0.006 mm, 0.31 ± 0.020 mm, respectively). FAME analysis revealed that saturated fatty acids dominated, especially in Smetol (97.6 ± 0.067%), while Coco24 had the highest levels of unsaturated fatty acids. Vita and Kospa received the highest panel ratings for smell, taste, and overall acceptability, indicating superior sensory appeal, whereas Smetol scored the lowest. Correlation analysis showed strong positive relationships between MUFA and PUFA (r = 0.986) and taste and acceptability (r = 0.993), as well as between antioxidant activity and Candida albicans inhibition (r = 0.859). Oxidative stability was negatively correlated with PUFA (r = –0.924). PCA grouped oils high in MUFA/PUFA (Kospa, Vita) with superior sensory scores, while PC2 reflected microbial safety. These differences suggest that Coco24, Health, Vita, and Kospa offer enhanced functional and sensory benefits, whereas Smetol is better suited for applications that prioritize oxidative stability. Full article

Background/Objectives: Metagenomic analyses are an important tool for understanding ecological effects, particularly in sites exposed to antimicrobial treatments. Marine sediments host diverse microbial communities and may serve as reservoirs for microbial resistance. Although it is known that antimicrobials can alter microbial composition, specific impacts on sediments surrounding salmon farms remain poorly understood. This study analyzed bacterial community structure in marine sediments subjected to florfenicol treatment from salmon farms in the Los Lagos Region of southern Chile. Methods: Sediment samples were collected and examined through DNA extraction and PCR amplification of the 16S rRNA gene (V3-V4 region). Sequences were analyzed using a bioinformatics pipeline, and amplicon sequence variants (ASVs) were taxonomically classified with a Naïve Bayesian classifier. The resulting ASV abundance were then used to predict metabolic functions and pathways via PICRUSt2, referencing the MetaCyc database. Results: Significant differences in bacterial phyla were observed between the control farm and two farms treated with florfenicol (17 mg kg⁻¹ body weight per day) for 33 and 20 days, respectively. Farm 1 showed notable differences in phyla such as Bacteroidota, Bdellovibrionota, Crenarchaeota, Deferrisomatota, Desulfobacterota, Fibrobacterota, Firmicutes, and Fusobacteriota, while Farm 2 exhibited differences in the phyla Bdellovibrionota, Calditrichota, Crenarchaeota, Deferrisomatota, Desulfobacterota, Fusobacteriota, Nanoarchaeota, and Nitrospirota. Shannon Index analysis revealed a reduction in alpha diversity in the treated farms. Comparative analysis between the control and the treated farms showed pronounced shifts in the relative abundance of several bacterial phyla, including statistically significant differences in Chloroflexi and Firmicutes. Predicted functional pathways revealed a notable enrichment of L-methionine biosynthesis III in Farm 2, suggesting a shift in sulfur metabolism potentially driven by antimicrobial treatment. Additionally, increased activity in fatty acid oxidation pathways indicates a higher microbial potential for lipid degradation at this site. Conclusions: These findings highlight the considerable influence of florfenicol on sediment microbial communities and reinforce the need for sustainable management strategies to minimize ecological disruption and the spread of antimicrobial resistance. Full article

Chitosan-based nanoparticles were prepared using an eco-friendly chemical procedure that conjugates natural fatty acids to the backbone of chitosan. This consists of reacting two molecules in the absence of a solvent and using microwaves to promote the chemical transformation. Both conditions make the whole chemical process more eco-compatible in terms of reagents and energy consumption. The chemical structure and the self-association behavior of chitosan–fatty acid conjugates were characterized by FT-IR, NMR, and dynamic light scattering. The conjugates displayed an enhanced solubility and efficient self-assembly in aqueous solution. The antimicrobial activity of the resulting nanoparticles was evaluated against Escherichia coli (Gram-negative) and Bacillus subtilis (Gram-positive). The micelles significantly inhibited E. coli growth (35–60%), even at relatively low concentrations, whereas negligible activity was observed against B. subtilis. The antibacterial efficacy appears to arise primarily from the ability of the developed nanostructured conjugates to perturb bacterial membranes. These results support the potential of chitosan–fatty acid conjugates as sustainable nanomaterials for biomedical applications, particularly as eco-friendly antimicrobial agents. Future work will evaluate their activity against other Gram-positive pathogens and explore their use in drug delivery. Full article